Welcome to visit Hotto!
Current location:front page >> healthy

Competition in the global health industry is becoming increasingly fierce

2025-09-19 04:52:22 healthy

Competition in the global health industry is becoming increasingly fierce

In recent years, the global health industry has shown a rapid development trend, especially in the post-epidemic era, countries have increased their investment in the field of medical and health, and technological innovation and market expansion have become the core of competition. The following is a compilation of popular topics and hot contents on the entire network in the past 10 days, and the competitive landscape of the global health industry is demonstrated through structured data.

1. Global health industry market size and growth

Competition in the global health industry is becoming increasingly fierce

areaMarket size in 2023 (USD 100 million)Annual growth rate (%)
North America1,2508.5
Europe9807.2
Asia Pacific1,10012.3
Latin America3206.8

From the data, it can be seen that the health industry in the Asia-Pacific region has the fastest growth, with an annual growth rate of up to 12.3%, far exceeding other regions. This is mainly due to the rapid rise of emerging markets such as China and India.

2. Popular health technology fields

Technical fieldAttention (%)Major countries/regions
Artificial Intelligence Medical35The United States, China, and the European Union
Gene Editing25United States, United Kingdom, China
Telemedicine20Globally
Biopharmaceuticals15United States, Germany, Japan

Artificial intelligence medical care has become the most concerned area, accounting for as much as 35%. Competitive competition in the field is particularly fierce among American and Chinese companies, such as Google DeepMind and Tencent Healthcare AI in China.

3. Recent hot events

In the past 10 days, there have been many major events in the global health industry:

  • Pfizer announces new anti-cancer drug entering clinical trial stage, expected to be launched in 2025.
  • Chinese pharmaceutical company BeiGene reached cooperation agreement with Novartis, jointly develop tumor immunotherapy.
  • EU passes new regulations, speed up the approval process of gene editing technology.

These events reflect that technological competition and cooperation in the global health industry are accelerating, and strategic alliances between multinational companies have become the norm.

4. Competitive landscape analysis

Company NameMarket value (USD 100 million)Main business areas
Johnson & Johnson4,200Pharmaceuticals, medical devices
Luo's3,800Biopharmaceuticals, diagnosis
Pfizer3,500Vaccines, innovative drugs
Hengrui Medicine600Anticancer drugs, generic drugs

From the perspective of corporate market value, European and American companies still dominate, but the rise of Chinese companies cannot be ignored. As a leading pharmaceutical company in China, Hengrui Medicine has a market value of over US$60 billion, becoming an important participant in the global health industry.

5. Future trend forecast

In the next five years, the global health industry will show the following trends:

  • Technological innovation accelerates: Technologies such as artificial intelligence and gene editing will be more widely used in the medical field.
  • Increased market concentration: Large multinational enterprises will integrate resources through mergers and acquisitions, and small and medium-sized enterprises are facing greater pressure.
  • Intensified policy impact: Governments will be more strict in the supervision of the health industry, and compliance costs will increase.

Overall, competition in the global health industry will become increasingly fierce, and technological innovation and market expansion have become the key to the survival and development of enterprises.

Next article
  • What medicine should I use for blister-type foot mossBlister-type foot moss is a common fungal infectious skin disease, mainly manifested in symptoms such as blisters, itching and peeling on the feet. Recently, the discussion on the treatment of blister-type foot moss on the entire network has been very popular. This article will combine popular topics and hot content in the past 10 days to introduce the medication p
    2025-09-29 healthy
  • China's innovative pharmaceutical companies face new challenges in expanding overseas marketsIn recent years, China's innovative pharmaceutical companies have made significant progress in R&D capabilities and international layout, but with the intensification of global market competition and changes in policy environment, overseas expansion faces new challenges. This article combines hot topics and data from the past
    2025-09-19 healthy
  • Yaotang Biotech completed more than 300 million yuan in round B financing, focusing on gene editing therapyRecently, the field of gene editing has received major news - Yaotang Biotech announced that it had completed a Series B financing of more than 300 million yuan, led by a number of well-known investment institutions. This round of financing will be mainly used to accelerate the company's R&D pipeline promotion,
    2025-09-19 healthy
  • Dual AAV gene therapy strategy brings new hope to patients with Usher type 1B retinopathyIn recent years, significant progress has been made in the field of gene therapy, especially in the treatment of rare hereditary diseases. Recently, a study on dual-AAV gene therapy strategies has brought new hope to patients with Usher type 1B retinopathy. This study not only demonstrates the potential of gene therapy, but also
    2025-09-19 healthy
Recommended articles
Reading rankings
Friendly links
Dividing line